LifeMD vs Medi-Weightloss: Prices, Programs & Reviews (2026)
Side-by-side comparison updated for 2026. ClearScores, pricing, medications, and ratings compared.
Quick Verdict
LifeMD has the higher ClearScore (76 vs 74)
LifeMD is more affordable ($189/mo vs $399/mo)
LifeMD has higher ratings (4.3/5 vs 4.2/5)
LifeMD scores better on value (4.2/5 vs 3.5/5)
LifeMD
$189/mo
starting price
Board-certified doctors prescribing GLP-1s with both compounded and brand-name options. Known for responsive customer service.
Medi-Weightloss
$399/mo
starting price
National franchise with 100+ clinics offering physician-supervised GLP-1 programs, nutrition counseling, and metabolic testing.
LifeMD vs Medi-Weightloss: Full Comparison
| LifeMD | Medi-Weightloss | |
|---|---|---|
| ClearScore | 76/100 ✓ | 74/100 |
| Overall Rating | 4.3/5 ✓ | 4.2/5 |
| Review Count | 165 | 342 ✓ |
| Starting Price | $189/mo ✓ | $399/mo |
| Medications | Compounded Semaglutide, Compounded Tirzepatide | Branded Semaglutide, Branded Tirzepatide |
| Telehealth | Yes | Yes |
| Insurance | Not accepted | Accepted |
| HSA/FSA | Accepted | Accepted |
| Founded | 2020 | 2007 |
| States Served | All 50 states | 19 states |
Programs & Pricing
LifeMD Programs
GLP-1 Weight Management
$189/mo
Medications: Compounded Semaglutide, Compounded Tirzepatide
- Medication
- Board Certified Doctor
- Ongoing Monitoring
- Free Shipping
Medi-Weightloss Programs
Signature Program
$399/mo
Medications: Branded Semaglutide, Branded Tirzepatide
- Medication
- In Person Visits
- Nutrition Counseling
- Metabolic Testing
- Body Composition
Ratings Breakdown
| Category | LifeMD | Medi-Weightloss |
|---|---|---|
| Overall | | |
| Value | | |
| Ease of Use | | |
| Support | | |
| Medication Quality | | |
| Results | | |
The Bottom Line
LifeMD edges out Medi-Weightloss with a ClearScore of 76 vs 74. LifeMD is more affordable starting at $189/mo compared to $399/mo. For customer support, LifeMD rates higher (4.6/5). The best choice depends on your priorities, medication preferences, and budget.